Does age limit the effectiveness of clinical pathways after coronary artery bypass graft surgery?

G Paone1, R S Higgins, S L Havstad

  • 1Division of Cardiac and Thoracic Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.

Circulation
|December 16, 1998
PubMed

Insights

Clinical pathways effectively reduce hospital stays after coronary artery bypass grafting (CABG). Elderly patients experience longer stays, primarily due to increased atrial fibrillation, but pathways may not need major changes.

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Medicine
  • Health Services Research

Background:

  • Clinical pathways are proven to shorten hospital stays post-coronary artery bypass grafting (CABG).
  • Limited research exists on the efficacy of these pathways specifically for elderly populations undergoing isolated CABG.

Purpose of the Study:

  • To evaluate the outcomes of a standardized 5-day postoperative clinical pathway for elderly patients (≥70 years) undergoing isolated CABG.
  • To compare the pathway's effectiveness in elderly versus younger patients (<70 years).

Main Methods:

  • Retrospective review of 445 consecutive patients undergoing isolated CABG.
  • Patients were divided into two groups: <70 years (n=299) and ≥70 years (n=146).
  • Analysis of preoperative characteristics, postoperative complications, length of stay, and mortality rates.

Main Results:

  • Elderly patients had higher rates of comorbidities, red blood cell transfusion, atrial fibrillation, and overall complications.
  • The mortality rate was higher in the elderly group (5.5% vs. 1.0%), as was the length of stay (7.9 vs. 6.4 days).
  • Multivariate analysis identified atrial fibrillation and red blood cell transfusion as key predictors of increased length of stay in elderly patients.

Conclusions:

  • Standard clinical pathways may be suitable for elderly patients undergoing isolated CABG without significant modifications.
  • The increased length of stay in elderly patients is primarily linked to a higher incidence of postoperative atrial fibrillation.
  • Focusing on managing complications like atrial fibrillation could optimize pathway success for older adults.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...